NCT05234463View on ClinicalTrials.gov

Study of the Link Between Complement Activation and IgA Nephropathy Severity

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
IgA Nephropathy Severity in Kidney Transplantation
Interventions
OTHER

IgAN patients

Adult patients Histologically proven diagnosis of IgA nephropathy Primary and secondary forms of the disease With or without kidney transplantation history Regardless of kidney/graft function Patients followed in the Nephrology Department of Strasbourg University Hospital.

Trial Locations (1)

Unknown

RECRUITING

Service de néphrologie, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER